{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:04:29Z","timestamp":1784246669304,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Xi\u2019an Science and Technology Plan Project","award":["24YXYJ0148"],"award-info":[{"award-number":["24YXYJ0148"]}]},{"name":"Scientific Research Fund Youth Project of the Second Affiliated Hospital of Xi\u2019an Jiaotong University","award":["YJ(QN)202325"],"award-info":[{"award-number":["YJ(QN)202325"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100359"],"award-info":[{"award-number":["82100359"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44385-9","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:02:35Z","timestamp":1779112955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between lactate-to-albumin ratio and 28-day mortality in critically ill patients with HFpEF: a retrospectively cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Tuo","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-e","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"44385_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","volume":"73","author":"K Omote","year":"2022","unstructured":"Omote, K., Verbrugge, F. H. & Borlaug, B. A. Heart failure with preserved ejection fraction: mechanisms and treatment strategies. Annu. Rev. Med. 73, 321\u2013337 (2022).","journal-title":"Annu. Rev. Med."},{"issue":"10431","key":"44385_CR2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","volume":"403","author":"P Campbell","year":"2024","unstructured":"Campbell, P. et al. Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet 403 (10431), 1083\u20131092 (2024).","journal-title":"Lancet"},{"issue":"6","key":"44385_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","volume":"18","author":"S Mishra","year":"2021","unstructured":"Mishra, S. & Kass, D. A. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Nat. Rev. Cardiol. 18 (6), 400\u2013423 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"44385_CR4","doi-asserted-by":"crossref","unstructured":"Abudureyimu, M. et al. Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics. J. Mol. Cell. Biol. 14(5), mjac028 (2022).","DOI":"10.1093\/jmcb\/mjac028"},{"issue":"6","key":"44385_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jchf.2023.03.011","volume":"11","author":"AS Desai","year":"2023","unstructured":"Desai, A. S. et al. How to manage heart failure with preserved ejection fraction: practical guidance for clinicians. JACC Heart Fail. 11 (6), 619\u2013636 (2023).","journal-title":"JACC Heart Fail."},{"key":"44385_CR6","doi-asserted-by":"crossref","unstructured":"Vrabie, A. M. et al. Biomarkers in heart failure with preserved ejection fraction: a perpetually evolving frontier. J. Clin. Med. 13(16), 4627 (2024).","DOI":"10.3390\/jcm13164627"},{"issue":"7","key":"44385_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s42255-020-0243-4","volume":"2","author":"JD Rabinowitz","year":"2020","unstructured":"Rabinowitz, J. D. & Enerb\u00e4ck, S. Lactate: the ugly duckling of energy metabolism. Nat. Metab. 2 (7), 566\u2013571 (2020).","journal-title":"Nat. Metab."},{"issue":"1","key":"44385_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41392-022-01151-3","volume":"7","author":"X Li","year":"2022","unstructured":"Li, X. et al. Lactate metabolism in human health and disease. Signal. Transduct. Target. Ther. 7 (1), 305 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"44385_CR9","doi-asserted-by":"publisher","first-page":"663560","DOI":"10.3389\/fnut.2021.663560","volume":"8","author":"GA Brooks","year":"2021","unstructured":"Brooks, G. A. Role of the heart in lactate shuttling. Front. Nutr. 8, 663560 (2021).","journal-title":"Front. Nutr."},{"key":"44385_CR10","doi-asserted-by":"crossref","unstructured":"Gajewski, P. et al. Lactate in heart failure. Int. J. Mol. Sci. 26(14), 6810 (2025).","DOI":"10.3390\/ijms26146810"},{"key":"44385_CR11","doi-asserted-by":"crossref","unstructured":"Ghazal, M. & Khalife, W. I. Hypoalbuminemia in heart failure: pathophysiology, clinical implications, and management strategies. Heart Fail. Rev. 30(6), 1407-1414 (2025).","DOI":"10.1007\/s10741-025-10558-3"},{"issue":"5","key":"44385_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11739-024-03612-9","volume":"19","author":"G Armentaro","year":"2024","unstructured":"Armentaro, G. et al. Prognostic role of serum albumin levels in patients with chronic heart failure. Intern. Emerg. Med. 19 (5), 1323\u20131333 (2024).","journal-title":"Intern. Emerg. Med."},{"key":"44385_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejim.2022.05.004","volume":"102","author":"AA Manolis","year":"2022","unstructured":"Manolis, A. A. et al. Low serum albumin: a neglected predictor in patients with cardiovascular disease. Eur. J. Intern. Med. 102, 24\u201339 (2022).","journal-title":"Eur. J. Intern. Med."},{"issue":"6","key":"44385_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s11739-024-03656-x","volume":"19","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Impact of lactate\/albumin ratio on prognostic outcomes in patients with concomitant heart failure and chronic kidney disease. Intern. Emerg. Med. 19 (6), 1625\u20131636 (2024).","journal-title":"Intern. Emerg. Med."},{"key":"44385_CR15","doi-asserted-by":"publisher","first-page":"1593524","DOI":"10.3389\/fmed.2025.1593524","volume":"12","author":"J Gou","year":"2025","unstructured":"Gou, J. et al. Prognostic value of the lactate-to-albumin ratio in critically ill chronic heart failure patients with sepsis: insights from a retrospective cohort study. Front. Med. (Lausanne). 12, 1593524 (2025).","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"44385_CR16","doi-asserted-by":"publisher","first-page":"33018","DOI":"10.1038\/s41598-025-18481-1","volume":"15","author":"K Han","year":"2025","unstructured":"Han, K. et al. Lactate-to-albumin ratio as an independent predictor of 28-day ICU mortality in patients with hypertension: a retrospective cohort study. Sci. Rep. 15 (1), 33018 (2025).","journal-title":"Sci. Rep."},{"issue":"2","key":"44385_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.21037\/atm-20-4519","volume":"9","author":"W Guo","year":"2021","unstructured":"Guo, W. et al. The value of lactate\/albumin ratio for predicting the clinical outcomes of critically ill patients with heart failure. Ann. Transl Med. 9 (2), 118 (2021).","journal-title":"Ann. Transl Med."},{"issue":"1","key":"44385_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s12872-025-04612-z","volume":"25","author":"Y Dong","year":"2025","unstructured":"Dong, Y. et al. The impact of the lactate-to-albumin ratio on long-term mortality risk in patients with severe heart failure and type 2 diabetes. BMC Cardiovasc. Disord. 25 (1), 234 (2025).","journal-title":"BMC Cardiovasc. Disord"},{"issue":"2","key":"44385_CR19","doi-asserted-by":"publisher","first-page":"e0282289","DOI":"10.1371\/journal.pone.0282289","volume":"18","author":"T Liu","year":"2023","unstructured":"Liu, T. et al. The association between serum albumin and long length of stay of patients with acute heart failure: a retrospective study based on the MIMIC-IV database. PLoS One. 18 (2), e0282289 (2023).","journal-title":"PLoS One"},{"issue":"1","key":"44385_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","volume":"10","author":"AEW Johnson","year":"2023","unstructured":"Johnson, A. E. W. et al. MIMIC-IV, a freely accessible electronic health record dataset. Sci. Data. 10 (1), 1 (2023).","journal-title":"Sci. Data"},{"issue":"10","key":"44385_CR21","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke, J. P. et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 4 (10), e297 (2007).","journal-title":"PLoS Med."},{"issue":"1","key":"44385_CR22","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/s41598-025-85931-1","volume":"15","author":"L Song","year":"2025","unstructured":"Song, L. et al. Propensity score matched cohort study on magnesium supplementation and mortality in critically ill patients with HFpEF. Sci. Rep. 15 (1), 1944 (2025).","journal-title":"Sci. Rep."},{"issue":"3","key":"44385_CR23","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/ehf2.14359","volume":"10","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Association between lactate\/albumin ratio and mortality in patients with heart failure after myocardial infarction. ESC Heart Fail. 10 (3), 1928\u20131936 (2023).","journal-title":"ESC Heart Fail."},{"issue":"16","key":"44385_CR24","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/eurheartj\/ehae868","volume":"46","author":"BJ van Essen","year":"2025","unstructured":"van Essen, B. J. et al. Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years. Eur. Heart J. 46 (16), 1528\u20131536 (2025).","journal-title":"Eur. Heart J."},{"key":"44385_CR25","doi-asserted-by":"crossref","unstructured":"Mih\u0103il\u0103, M-D. et al. Beyond traditional risk factors: integrating epicardial adipose tissue into the comorbidity landscape of HFpEF. J Clin Med. 14(17), 6139 (2025).","DOI":"10.3390\/jcm14176139"},{"issue":"7752","key":"44385_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella, G. G. et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568 (7752), 351\u2013356 (2019).","journal-title":"Nature"},{"issue":"7","key":"44385_CR27","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"SD Anker","year":"2023","unstructured":"Anker, S. D. et al. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur. J. Heart Fail. 25 (7), 936\u2013955 (2023).","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"44385_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12933-025-02720-w","volume":"24","author":"YJ Song","year":"2025","unstructured":"Song, Y. J. et al. Epicardial adipose tissue and heterogeneity parameters combined with inflammatory cells to predict the value of heart failure with preserved ejection fraction patients post myocardial infarction. Cardiovasc. Diabetol. 24 (1), 192 (2025).","journal-title":"Cardiovasc. Diabetol."},{"issue":"3","key":"44385_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cardfail.2022.09.018","volume":"29","author":"M Obokata","year":"2023","unstructured":"Obokata, M. et al. Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan. J. Card Fail. 29 (3), 375\u2013388 (2023).","journal-title":"J. Card Fail."},{"issue":"2","key":"44385_CR30","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ehf2.15128","volume":"12","author":"S Verstreken","year":"2025","unstructured":"Verstreken, S. et al. eGFR slope as predictor of mortality in heart failure patients. ESC Heart Fail. 12 (2), 1217\u20131226 (2025).","journal-title":"ESC Heart Fail."},{"key":"44385_CR31","doi-asserted-by":"crossref","unstructured":"Doi, S. et al. Determinants of submaximal exercise intolerance in patients with heart failure and preserved ejection fraction: Insights from the lactate threshold. Eur. J. Heart Fail. 27(12), 3193-3204 (2025).","DOI":"10.1002\/ejhf.3729"},{"issue":"12","key":"44385_CR32","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cardfail.2020.07.010","volume":"26","author":"C Hage","year":"2020","unstructured":"Hage, C. et al. Metabolomic Profile in HFpEF vs HFrEF Patients. J. Card Fail. 26 (12), 1050\u20131059 (2020).","journal-title":"J. Card Fail."},{"issue":"5","key":"44385_CR33","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/ehf2.14794","volume":"11","author":"E Nan Tie","year":"2024","unstructured":"Nan Tie, E. et al. Hyperlactataemia is a marker of reduced exercise capacity in heart failure with preserved ejection fraction. ESC Heart Fail. 11 (5), 2557\u20132565 (2024).","journal-title":"ESC Heart Fail."},{"key":"44385_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2018.04.014","volume":"52","author":"S Arques","year":"2018","unstructured":"Arques, S. Human serum albumin in cardiovascular diseases. Eur. J. Intern. Med. 52, 8\u201312 (2018).","journal-title":"Eur. J. Intern. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44385-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44385-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T23:27:49Z","timestamp":1784244469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44385-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44385"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44385-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The review boards of the Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center approved the use of the MIMIC-IV database. Since the participants in the study were anonymized and deidentified, this study was exempt from the requirements for ethical approval and informed consent.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"22471"}}